(2S,3S,4S,5S,6S)-6-[(1R,2R,4S,5R,8S,10S,13S,14R,17S,18R,21R,22R,23S)-2,23-dihydroxy-4,5,9,9,13,20,20-heptamethyl-21-[(Z)-2-methylbut-2-enoyl]oxy-22-[(Z)-3-phenylprop-2-enoyl]oxy-24-oxahexacyclo[15.5.2.01,18.04,17.05,14.08,13]tetracosan-10-yl]-4-[(2S,3R,4S,5R,6R)-3-[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxy-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2-carboxylic acid

Details

Top
Internal ID 19f56fa2-3b21-441d-ae99-0259c71f9b29
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Terpene glycosides > Triterpene glycosides > Triterpene saponins
IUPAC Name (2S,3S,4S,5S,6S)-6-[(1R,2R,4S,5R,8S,10S,13S,14R,17S,18R,21R,22R,23S)-2,23-dihydroxy-4,5,9,9,13,20,20-heptamethyl-21-[(Z)-2-methylbut-2-enoyl]oxy-22-[(Z)-3-phenylprop-2-enoyl]oxy-24-oxahexacyclo[15.5.2.01,18.04,17.05,14.08,13]tetracosan-10-yl]-4-[(2S,3R,4S,5R,6R)-3-[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxy-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2-carboxylic acid
SMILES (Canonical) CC=C(C)C(=O)OC1C(C23C(CC1(C)C)C4(CCC5C6(CCC(C(C6CCC5(C4(CC2O)C)C)(C)C)C7C(C(C(C(O7)C(=O)O)O)OC8C(C(C(C(O8)CO)O)O)OC9C(C(C(C(O9)C)O)O)OC1C(C(C(C(O1)C)O)O)O)OC1C(C(C(C(O1)CO)O)O)O)C)OC3O)OC(=O)C=CC1=CC=CC=C1
SMILES (Isomeric) C/C=C(/C)\C(=O)O[C@H]1[C@@H]([C@]23[C@@H](C[C@]4([C@@]5(CC[C@@H]6[C@@]([C@H]5CC[C@@]4([C@@H]2CC1(C)C)O[C@@H]3O)(CC[C@@H](C6(C)C)[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)O)O)O[C@H]8[C@@H]([C@H]([C@H]([C@H](O8)CO)O)O)O[C@H]9[C@@H]([C@@H]([C@H]([C@@H](O9)C)O)O)O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C)O)O)O)O[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O)C)C)C)O)OC(=O)/C=C\C1=CC=CC=C1
InChI InChI=1S/C74H110O31/c1-12-30(2)62(92)104-59-60(98-41(78)19-18-33-16-14-13-15-17-33)74-39(26-68(59,5)6)73(105-67(74)93)25-22-38-70(9)23-20-34(69(7,8)37(70)21-24-71(38,10)72(73,11)27-40(74)77)53-58(103-64-51(88)47(84)44(81)35(28-75)96-64)54(52(89)55(99-53)61(90)91)100-66-57(49(86)45(82)36(29-76)97-66)102-65-56(48(85)43(80)32(4)95-65)101-63-50(87)46(83)42(79)31(3)94-63/h12-19,31-32,34-40,42-60,63-67,75-77,79-89,93H,20-29H2,1-11H3,(H,90,91)/b19-18-,30-12-/t31-,32-,34+,35+,36+,37-,38+,39-,40+,42-,43-,44-,45-,46+,47-,48+,49-,50+,51+,52-,53-,54-,55-,56+,57+,58-,59-,60-,63-,64-,65-,66-,67-,70-,71+,72-,73-,74+/m0/s1
InChI Key MDKMWDRBFFTMEG-PMSANBETSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C74H110O31
Molecular Weight 1495.60 g/mol
Exact Mass 1494.7031067 g/mol
Topological Polar Surface Area (TPSA) 486.00 Ų
XlogP 2.20
Atomic LogP (AlogP) -1.06
H-Bond Acceptor 30
H-Bond Donor 16
Rotatable Bonds 17

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (2S,3S,4S,5S,6S)-6-[(1R,2R,4S,5R,8S,10S,13S,14R,17S,18R,21R,22R,23S)-2,23-dihydroxy-4,5,9,9,13,20,20-heptamethyl-21-[(Z)-2-methylbut-2-enoyl]oxy-22-[(Z)-3-phenylprop-2-enoyl]oxy-24-oxahexacyclo[15.5.2.01,18.04,17.05,14.08,13]tetracosan-10-yl]-4-[(2S,3R,4S,5R,6R)-3-[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxy-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2-carboxylic acid

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.8710 87.10%
Caco-2 - 0.8588 85.88%
Blood Brain Barrier - 0.6250 62.50%
Human oral bioavailability - 0.8571 85.71%
Subcellular localzation Mitochondria 0.8066 80.66%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.7988 79.88%
OATP1B3 inhibitior + 0.9127 91.27%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior - 0.9000 90.00%
BSEP inhibitior + 0.9734 97.34%
P-glycoprotein inhibitior + 0.7426 74.26%
P-glycoprotein substrate + 0.7069 70.69%
CYP3A4 substrate + 0.7512 75.12%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8770 87.70%
CYP3A4 inhibition - 0.6145 61.45%
CYP2C9 inhibition - 0.7382 73.82%
CYP2C19 inhibition - 0.8487 84.87%
CYP2D6 inhibition - 0.9272 92.72%
CYP1A2 inhibition - 0.8649 86.49%
CYP2C8 inhibition + 0.8422 84.22%
CYP inhibitory promiscuity - 0.9036 90.36%
UGT catelyzed - 0.5000 50.00%
Carcinogenicity (binary) - 0.9800 98.00%
Carcinogenicity (trinary) Non-required 0.5788 57.88%
Eye corrosion - 0.9895 98.95%
Eye irritation - 0.8962 89.62%
Skin irritation - 0.6304 63.04%
Skin corrosion - 0.9405 94.05%
Ames mutagenesis - 0.6078 60.78%
Human Ether-a-go-go-Related Gene inhibition + 0.7642 76.42%
Micronuclear - 0.7200 72.00%
Hepatotoxicity - 0.7209 72.09%
skin sensitisation - 0.8946 89.46%
Respiratory toxicity + 0.7111 71.11%
Reproductive toxicity + 0.9222 92.22%
Mitochondrial toxicity + 0.5500 55.00%
Nephrotoxicity - 0.9370 93.70%
Acute Oral Toxicity (c) I 0.7298 72.98%
Estrogen receptor binding + 0.5962 59.62%
Androgen receptor binding + 0.7652 76.52%
Thyroid receptor binding + 0.7463 74.63%
Glucocorticoid receptor binding + 0.8168 81.68%
Aromatase binding + 0.7355 73.55%
PPAR gamma + 0.8230 82.30%
Honey bee toxicity - 0.6023 60.23%
Biodegradation - 0.8500 85.00%
Crustacea aquatic toxicity + 0.5245 52.45%
Fish aquatic toxicity + 0.9894 98.94%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.38% 91.11%
CHEMBL221 P23219 Cyclooxygenase-1 98.56% 90.17%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 98.00% 96.09%
CHEMBL1293249 Q13887 Kruppel-like factor 5 97.76% 86.33%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 93.99% 95.56%
CHEMBL2035 P08912 Muscarinic acetylcholine receptor M5 92.99% 94.62%
CHEMBL4302 P08183 P-glycoprotein 1 92.61% 92.98%
CHEMBL2581 P07339 Cathepsin D 92.57% 98.95%
CHEMBL3714130 P46095 G-protein coupled receptor 6 92.44% 97.36%
CHEMBL216 P11229 Muscarinic acetylcholine receptor M1 92.30% 94.23%
CHEMBL3807 P17706 T-cell protein-tyrosine phosphatase 91.81% 93.00%
CHEMBL1821 P08173 Muscarinic acetylcholine receptor M4 91.60% 94.08%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 91.33% 96.00%
CHEMBL1806 P11388 DNA topoisomerase II alpha 90.53% 89.00%
CHEMBL3137262 O60341 LSD1/CoREST complex 90.13% 97.09%
CHEMBL4227 P25090 Lipoxin A4 receptor 85.93% 100.00%
CHEMBL5028 O14672 ADAM10 85.55% 97.50%
CHEMBL2007 P16234 Platelet-derived growth factor receptor alpha 84.78% 91.07%
CHEMBL3401 O75469 Pregnane X receptor 84.21% 94.73%
CHEMBL1994 P08235 Mineralocorticoid receptor 84.13% 100.00%
CHEMBL5608 Q16288 NT-3 growth factor receptor 83.92% 95.89%
CHEMBL3091268 Q92753 Nuclear receptor ROR-beta 83.81% 95.50%
CHEMBL3359 P21462 Formyl peptide receptor 1 80.28% 93.56%
CHEMBL218 P21554 Cannabinoid CB1 receptor 80.04% 96.61%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Maesa balansae

Cross-Links

Top
PubChem 102354528
LOTUS LTS0256836
wikiData Q105161817